Drugs / Sm14
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03799510 | Dec 2018 → Jul 2019 | schistosomiasis | Oswaldo Cruz Foundation | Completed | No outcome recorded |
| Phase 2 | NCT03041766 | Dec 2016 → Apr 2017 | schistosomiasis | Oswaldo Cruz Foundation | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sm14 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03799510 ↗ |
| Modality | Protein / enzyme biologic | “Sm14: recombinant protein produced in yeast following Good Manufacturing Practices (GMP) conditions” NCT03041766 ↗ |
| Route | Intramuscular | “intra-muscular injections” NCT03041766 ↗ |